Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 7,250 shares of common stock on April 21, 2024, to satisfy tax withholding obligations.
Summary
- On April 21, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 7,250 shares of common stock.
- The transaction was executed to cover tax obligations related to equity compensation.
- Following the transaction, Mertens directly owns 176,661 shares of NeuroOne Medical Technologies Corp.
- The shares were disposed of at a price of $1.15.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The disposal of shares by an executive could be perceived negatively by some shareholders, although it is a common practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/21/2024 | Date of transaction: Steve Mertens disposed of 7,250 shares of common stock. |
| 04/23/2024 | Date of signature: Stephanie Swan, by Power of Attorney, signed the Form 4 on behalf of Steve Mertens. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.